Strain selection and scale-up fermentation for FR901379 acylase production by Streptomyces sp. no. 6907(METHOD)
スポンサーリンク
概要
- 論文の詳細を見る
Micafungin (FK463) is a widely used treatment for life-threatening, deep-seated fungal infections. It is an echinocandinlike lipopeptide derived from the chemical modification of deacylated FR901379, a type of lipopeptide antibiotic produced by Coleophoma empetri F-11899. The palmitoyl moiety of FR901379 is deacylated by FR901379 acylase produced by Streptomyces sp. no. 6907. In this study, our goal was to generate an improved strain of Streptomyces sp. no. 6907 capable of hyperproducing the FR901379-acylase enzyme. To accomplish this goal, modified strains of Streptomyces sp. no. 6907 were generated using UV-irradiation mutagenesis, and strain selection was performed using an agar-plate screening method to efficiently select an acylase-hyperproducing strain. Three marker indices were shown to correlate with elevated acylase production: decreased candidacidal activity of FR901379, decreased proteolytic activity on skim milk, and phenotypic characteristics. Cloning and subsequent sequencing of the acylase gene from the hyperproducing mutant revealed no mutations in either the acylase structural gene or the 5'-flanking region required for gene expression. The growth medium was also modified to maximize acylase production. We successfully increased acylase activity approximately 65-fold, compared with the original growth conditions (wild strain cultured in the original unmodified medium). To minimize formation of excess foam during the fermentation process, we optimized the parameters of agitation speed, as calculated from the discharge flow rate. Using our improved strain and the optimized medium and growth conditions, we have developed an improved and highly reproducible method for stable large-scale production of FR901379-acylase.
著者
-
Isogai Yasuhiro
Department Of Biotechnology Toyama Prefectural University
-
Hashimoto Michizane
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Tsuboi Masaru
Fermentation And Biotechnology Laboratories Astellas Pharma Inc.
-
Shimizu Shiho
Fermentation And Biotechnology Laboratories Astellas Pharma Inc.
-
Yamada Masato
Department Of Biotechnology Toyama Prefectural University
-
Hashimoto Seiji
Department Of Nephrology Division Sapporo General City Hospital
-
Hino Motohiro
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Hashimoto Seiji
Department Of Biotechnology Toyama Prefectural University
-
Hino Motohiro
Fermentation And Biotechnology Laboratories Astellas Pharma Inc.
-
Tanaka Fumihiro
Fermentation And Biotechnology Laboratories Astellas Pharma Inc.
-
Yamada Masato
Biotechnology Research Center Faculty Of Engineering Toyama Prefectural University
-
Ueda Satoshi
Fermentation And Biotechnology Laboratories Astellas Pharma Inc.
-
Kinoshita Masayoshi
Fermentation and Biotechnology Laboratories, Astellas Pharma Inc.
-
Oohata Nobutaka
Fermentation and Biotechnology Laboratories, Astellas Pharma Inc.
-
Isogai Yasuhiro
Biotechnology Research Center, Faculty of Engineering, Toyama Prefectural University
-
Hashimoto Seiji
Biotechnology Research Center, Faculty of Engineering, Toyama Prefectural University
-
Isogai Yasuhiro
Biotechnology Research Center Faculty Of Engineering Toyama Prefectural University
-
Kinoshita Masayoshi
Fermentation And Biotechnology Laboratories Astellas Pharma Inc.
-
Shimizu Shiho
Fermentation And Biotechnology Laboratories Astellas Pharma Inc.:(present Office)project And Quality
-
Tsuboi Masaru
Fermentation And Biotechnology Laboratories Astellas Pharma Inc.:(present Office)toyama Technology C
-
Hashimoto Seiji
Biotechnology Research Center Faculty Of Engineering Toyama Prefectural University
-
Ueda Satoshi
Fermentation And Biotechnology Laboratories
-
Oohata Nobutaka
Fermentation And Biotechnology Laboratories
-
Hashimoto Seiji
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
関連論文
- Improvement of FR901379 production by mutant selection and medium optimization(BIOCHEMICAL ENGINEERING)
- Preliminary evaluation of image reconstruction by ordered-subset expectation maximization in thallium-201 lung scintigraphy
- Miniaturized Vision System for Microfluidic Devices
- 1P039 抗生物質代謝酵素の基質結合シミュレーション(蛋白質-構造機能相関,第48回日本生物物理学会年会)
- The Novel Gluconeogenesis Inhibitors FR225659 and Related Compounds that Originate from Helicomyces sp. No. 19353 : II. Biological Profiles
- Naphthalecin, a Novel Antibiotic Produced by the Anaerobic Bacterium, Sporotalea colonica sp. nov.
- FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919 : II. Biological Profiles
- FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919 : I. Taxonomy of the Producing Organism, Fermentation, Islation and Physico-chemical Properties
- FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604 : II. Biological Activities
- FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties
- The Novel Gluconeogenesis Inhibitors FR225659 and Related Compounds that Originate from Helicomyces sp. No.19353 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
- FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) II. Biological Activities in Animal Models
- FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 III. In Vivo Activities
- FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) I. Taxonomy, Fermentation, Isolation and Biological Activities
- FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 II. In Vitro Property and Mode of Action
- FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No.11243 : II. In Vitro and In Vivo Activities
- Steroid-sensitive nephrotic syndrome associated with positive C1q immunofluorescence
- Unilateral renal cortical necrosis with contralateral hydronephrosis after surgery for uterus carcinoma
- FR227673 and FR190293, Novel Antifungal Lipopeptides from Chalara sp. No. 22210 and Tolypocladium parasiticum No. 16616
- FR207944, an Antifungal Antibiotic from Chaetomium sp. No. 217 : I. Taxonomy, Fermentation, and Biological Properties
- FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002 : II. Biological Properties and Model of Action
- FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase III. Structure Determination
- A New Antimitotic Substance, FR182877 : II. The Mechanism of Action
- Site-specific Structural Transformation of the Novel Antifungal Cyclic Depsipeptide FR901469 : Synthesis and Biological Activity of FR203904
- FR220897 and FR220899, Novel Antifungal Lipopeptides from Coleophoma empetri No. 14573
- FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738 : II. In Vitro and In Vivo Antifungal Activity
- FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
- FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No. 11243 : III. Structure Determination
- FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No.11243 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Properties
- FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
- FR198248, a New Anti-influenza Agent isolated from Aspergillus terreus No.13830 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- Cavitary lung lesion in a patient with systemic lupus erythematosus : an unusual manifestation of cytomegalovirus pneumonitis
- FR207944, an Antifungal Antibiotic from Chaetomium sp. No. 217 : II. Isolation and Structure Elucidation
- Oxidative Activities of Heterologously Expressed CYP107B1 and CYP105D1 in Whole-Cell Biotransformation Using Streptomyces lividans TK24(ENZYMOLOGY, PROTEIN ENGINEERING, AND ENZYME TECHNOLOGY)
- The Novel Gluconeogenesis Inhibitor FR225654 that Originates from Phoma sp. No. 00144 : II. Biological Activities
- The Novel Gluconeogenesis Inhibitor FR225654 that Originates from Phoma sp. No. 00144 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
- The Novel Gluconeogenesis Inhibitors FR225659 and FR225656 from Helicomyces sp. No. 19353 : III. Structure Determination
- FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 I. Taxonomy, Ferimentation, Isolation, Physico-chemical Properties and Biological Activities of FR252921, FR252922 and FR256523
- New Anti-influenza Agents, FR198248 and Its Derivatives : II. Characterization of FR198248, Its Related Compounds and Some Derivatives
- FR191512 , a Novel Anti-influenza Agent Isolated from a Fungus Strain No.17415 : II. Biological Properties
- FR191512 , a Novel Anti-influenza Agent Isolated from a Fungus Strain No.17415 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Structure Elucidation
- Bubble Motion and its Surrounding Liquid Motion through the Collision of a pair of Bubbles
- WA8242A_1, A_1 and B, Novel Secretory Phospholipase A_1 Inhibitors Produced by Streptomyces violaceusniger I. Taxonomy, Production and Purification
- FR225659-binding Proteins : Identification as Serine/Threonine Protein Phosphatase PP1 and PP2A Using High-performance Affinity Beads
- A Comparative Study of Malaysian and Japanese Actinomycetes Using a Simple Identification Method Based on Partial 16S rDNA Sequence
- A New Antimitotic Substance, FR182877 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- Pulmonary Hyalinizing Granuloma with Hydronephrosis
- WF14865A and B, New Cathepsins B and L Inhibitors Produced by Aphanoascus fulvescens I. Taxonomy, Production, Purification and Biological Properties
- WF14861, a New Cathepsins B and L Inhibitor Produced by Colletotrichum sp. I. Taxonomy, Production Purification and Structure Elucidation
- WF14861, a New Cathepsins B and L Inhibitor Produced by Collectotrichum sp. II. Biological Properties
- WA8242A_1, A_2 and B, Novel Secrtory Phospholipase A_2 Inhibitors Produced by Streptomyces violaceusniger II. Biological Properties
- Bubble Splitting by Turbulent Jet Emitted from Orifice
- Strain selection and scale-up fermentation for FR901379 acylase production by Streptomyces sp. no. 6907(METHOD)
- Cloning and expression of the FR901379 acylase gene from Streptomyces sd. no. 6907
- Anti-herpes virus activity of polyether antibiotic CP-44161 in vivo
- Discovery of anti-varicella zoster virus activity of polyether antibiotic CP-44161
- Screening and characterization of microorganisms with FR901379 acylase activity
- AS1387392, a novel immunosuppressive cyclic tetrapeptide compound with inhibitory activity against mammalian histone deacetylase
- Cloning and heterologous expression of P450Um-1, a novel bacterial P450 gene, for hydroxylation of immunosuppressive agent AS1387392
- Bioconversion of AS1387392 : bioconversion studies involving Amycolatopsis azurea JCM 3275
- Bioconversion of AS1387392 : screening and characterization of actinomycetes that convert AS1387392 to AS1429716
- Micafungin : a sulfated echinocandin
- A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler's disease
- Characterization of a gene coding for a putative adenosine deaminase-related growth factor by RNA interference in the Basidiomycete Flammulina velutipes(GENETICS, MOLECULAR BIOLOGY, AND GENE ENGINEERING)
- Sapphirine from Metamorphosed Layered Complex of Mt. Poroshiri, Hidaka Metamorphic Belt, Hokkaido
- Enhanced oxidative activities of cytochrome P450Rhf from Rhodococcus sp. expressed using the hyper-inducible expression system(GENETICS, MOLECULAR BIOLOGY, AND GENE ENGINEERING)